PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Vertically Urban (VU) is a horticultural lighting specialist that produces high-tech LED lighting solutions for indoor industrial farms, glasshouses, medicinal growers and onsite Pod farms, who in turn, supply to supermarkets, restaurants and the medical market. The company aims to be a segment leader in the global vertical farming market that is projected to reach $12.7 billion by 2026. VU asserts that vertical farming has been tipped as the future of food production and supported by early investors such as Amazon’s Jeff Bezos. The company has witnessed £30 million+ worth of sales to date. It will use the investment to increase brand awareness via horticultural trade shows, market its products on online and offline portals, develop new technologies, and recruit senior personnel to oversee growth in key markets.
days to go:
Expired
investment:
£335,040
East London Liquor Company (ELLC) has been distilling, importing and serving gins, whiskies, vodkas, rums, and canned cocktails since 2014. ELLC asserts that off-trade gin sales hit US$8.4 billion in 2020 with UK seltzer sales expected to reach £75 million by 2023. It intends to become a contender in the aforementioned categories. ELLC has had a 600% Year-on-Year (YoY) increase to £206,000 in off-trade sales from 2019-2020 to 2020-2021. The company has partnered with the UNESCO world heritage site, Royal Botanic Gardens, Kew, to release its product, Kew Gin. It has also entered into the Ready-To-Drink and seltzer categories with its range of canned drinks, and onboarded retailers like Waitrose, Tesco, and Co-Op. The company will use the investment to grow its off-trade channels both in the UK and abroad, expand its Direct To Consumer (DTC) output, update its 'Brand Home' to attract more customers, and increase its whisky production to meet demand.
days to go:
Expired
investment:
£921,686
A socially led clothing brand relaunched in 2017 with three dedicated stores, as well as goods available in more than 150 retailers across the UK. Rupert and Buckley has recently acquired a new distribution centre and is the Leisurewear partner of 'The Boat Race’, which has a global audience of over 6 million.
days to go:
Expired
investment:
£94,860
Deciwatt develops renewable energy solutions and its new product (nowlight), creates instant power and light from the pull of a cord. This company created 'nowlight' leveraging on the success of its first product ‘GravityLight’, which had secured media coverage from around the world, won many awards and was sold by major retailers like Best Buy and Walmart. Additionally, it has been awarded a new £173,788 grant from Innovate UK to integrate Pay-As-You-Go technology into nowlight. Further, this company has a pending registered trademark on the nowlight name and a patent pending on the manual power generation mechanism. It will invest the fund raised in implementing its marketing plans, further product development, and scale up its marketing activity and develop its business.
days to go:
Expired
investment:
£519,607
Aiming to improve the health and well-being of the UK by incorporating spa and beauty treatments into everyday life. PURE is a profitable business that currently runs 8 urban spas across Great Britain, as well as selling their own range of natural products and treatments for skincare to be used at home. Over 100k clients a year have used PURE's services, with 40% of appointments being booked via the company's website and mobile app. This has resulted in sales of £2.9m in 2017, with group revenue increasing by more than 21% in the year-to-date.
Investments will be used to open in more locations, develop more products and expand the PURE Beauty Zone marketplace for independent health and beauty businesses to sell their products in PURE's spas and on their website.
days to go:
Expired
investment:
£72,650
